Volume 88, Issue 6, Pages 1411-1418 (December 2015) Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates Markus P. Schneider, Silvia Hübner, Stephanie I. Titze, Matthias Schmid, Jennifer Nadal, Georg Schlieper, Martin Busch, Seema Baid- Agrawal, Vera Krane, Christoph Wanner, Florian Kronenberg, Kai-Uwe Eckardt Kidney International Volume 88, Issue 6, Pages 1411-1418 (December 2015) DOI: 10.1038/ki.2015.246 Copyright © 2015 International Society of Nephrology Terms and Conditions
Figure 1 Application of the new Kidney Disease: Improving Global Outcomes (KDIGO) guideline to patients 18–49 years in the German Chronic Kidney Disease (GCKD) cohort. Kidney International 2015 88, 1411-1418DOI: (10.1038/ki.2015.246) Copyright © 2015 International Society of Nephrology Terms and Conditions
Figure 2 Percent of patients ≥50 years in the German Chronic Kidney Disease (GCKD) cohort exceeding various thresholds of 10-year risk for coronary heart disease according to the Framingham-coronary heart disease (CHD) risk equations. Kidney International 2015 88, 1411-1418DOI: (10.1038/ki.2015.246) Copyright © 2015 International Society of Nephrology Terms and Conditions
Figure 3 Percent of patients ≥50 years in the German Chronic Kidney Disease (GCKD) cohort exceeding various thresholds of 10-year risk of an atherosclerotic event according to the American College of Cardiology and the American Heart Association (ACC-AHA) risk equations. Kidney International 2015 88, 1411-1418DOI: (10.1038/ki.2015.246) Copyright © 2015 International Society of Nephrology Terms and Conditions